Tag: drug-induced
-
Diabetes Drug Tradjenta Associated With Bullous Pemphigoid, A Chronic Blistering Skin Condition
Bullous Pemphigoid (BP) Is An Auto-Immune Skin Disease Which Can Be Fatal, Particularly In Patients Who Are Debilitated (Posted by Tom Lamb at DrugInjuryWatch.com) Three relatively new medical studies add weight to…
-
Like Depakote, Stavzor Can Cause Liver Failure, Usually During First 6 Months; Children Under Age 2 Are At A Higher Risk, As Are Patients with Mitochondrial Disease
Black-Box Warning Added To Stavzor Label Announced By FDA In March 2014, Almost Full Year After Similar Label Change For Depakote Hepatotoxicity (Posted by Tom Lamb at DrugInjuryWatch.com)Stavzor, a lesser known valproic acid medication…
-
Antibiotics Levaquin And Avelox Linked To Increased Risk Of Liver Injury In Older Patients According To New Canadian Study
August 2012 CMAJ Medical Journal Article Adds To Hepatotoxicity Evidence Against These Two Fluoroquinolone Drugs (Posted by Tom Lamb at DrugInjuryWatch.com) According to a case-control study published by the Canadian Medical Association Journal (CMAJ)…
-
Multaq Update: European Safety Review Expanded To Cardiovascular Side Effects Risk In July 2011
EMA And FDA Already Had Sanofi Issue A "Dear Doctor" Letter About Liver Failure In January 2011 (Posted by Tom Lamb at DrugInjuryWatch.com) ______________________________________________________________________________ UPDATE: The FDA announced on July 21, 2011 that it…
-
Acute Pancreatitis Case Associated With Victoza Use, Similar To Byetta And Januvia Case Reports
Drug Safety Issue Controversy Continues: True Serious Side Effect, Or Attributable To Type 2 Diabetes Condition (Posted by Tom Lamb at DrugInjuryWatch.com) ______________________________________________________________________________ UPDATE: Victoza (liraglutide [rDNA origin]) Injection: REMS – Risk of Thyroid…
-
Case Report Of Woman With Likely Byetta-Induced Acute Pancreatitis
August 2009 Medical Journal Article Presents Well-Documented Report Of Pancreatitis In Context Of Byetta Use (Posted by Tom Lamb at DrugInjuryWatch.com) In October 2007 the FDA announced that the agency had reviewed 30 postmarketing…
-
Some Criteria To Determine A New Drug’s Potential For Causing Severe Drug-Induced Liver Injury (DILI)
In July 2009 FDA Issues Updated Guidance For Industry Document Concerning DILI In Premarketing Clinical Evaluation (Posted by Tom Lamb at DrugInjuryWatch.com) In July 2009 the FDA issued a Guidance for Industry document intended for pharmaceutical…